Intravenous Iron for Heart Failure: Where Is the Evidence?

28th Annual Heart Failure 2024: An Update on Therapy

I. Pina

Overview Tobacco and Nicotine Dependence

The University of Texas MD Anderson Cancer Center

M. A. Karam Hage, MD

Identifying Patients at Risk for Cardiac Toxicity With Cancer Therap…

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

A. Narezkina

Reducing Cardiovascular Risk in Our Patients: Case Presentation

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

A. Narezkina

Overview of Iron Deficiency in Heart Failure & Recognizing Iron Defi…

ACHL

M. Vaduganathan

Treatment of Iron Deficiency Across the Heart Failure Spectrum

ACHL

S. Gale

Managing Cardiotoxicities in TKI Therapy for CLL: Atrial Fibrillatio…

Avirup Guha

Iron Deficiency in Heart Failure - San Diego

San Diego Heart Failure Symposiums

H. Shapiro

Managing Cardiotoxicities in BTKi Treatment for CLL: Atrial Fibrilla…

Lydia Scarfò

Treating Amyloidosis in 2024

MyCancerHaven

R. Vij, J. Zonder

2023 Update on Cardiac Amyloid

MUSC Cardiology

J. Griffin

Iron Deficiency Cases and Panel Discussions

ACHL

A. Mardis, S. Gale, M. Vaduganathan

Strategies for Assessing and Managing DOAC-Related Bleeding

The France Foundation

D. Siegal, A. (Ander) Cohen

Practical Approaches to IV Iron Administration

ACHL

A. Mardis

Peptide Treatment for Cancer and Heart Failure Induced Muscle Wasting

University of Louisville

S. P Baba

Iron Deficiency Question & Answer Highlights

ACHL

A. Mardis, S. Gale, M. Vaduganathan

ACC 2022: Triple Therapy - When to Use and How Long

ACC 2022 Conference Coverage

D. Kumbhani

Heart Failure Therapy: Focus on Guidelines

St. Louis Shock & Heart Failure Symposium 2022

J. Vader

Innovations at The Texas Heart Institute: Improving Access to Heart …

The Texas Heart Institute

A. Nair

Cardiovascular Genomic & Precision Medicine: The Future Is Today!

Georgia Heart Institute

A. Chahal